From: Conditional survival of cancer patients: an Australian perspective
Type of cancer | Number of patients | Estimated conditional 5-year relative survival (95% confidence intervals) | ||||
---|---|---|---|---|---|---|
At diagnosis | 1 year after diagnosis | 3 years after diagnosis | 5 years after diagnosis | 10 years after diagnosis | ||
Stomach | 5,193 | 28.5 | 51.3 | 79.4 | 91.0 | 95.0 |
(27.2-29.8) | (48.8-53.8) | (76.2-82.6) | (87.6-94.3) | (91.0-98.9) | ||
Colorectum | 35,455 | 65.0 | 75.5 | 86.8 | 93.2 | 98.8 |
(64.4-65.7) | (74.8-76.3) | (86.0-87.6) | (92.3-94.0) | (97.7-99.9) | ||
Pancreas | 5,213 | 5.6 | 21.9 | 64.3 | 81.8 | 94.7 |
(5.0-6.3) | (19.2-24.7) | (56.9-71.7) | (73.8-89.9) | (86.1-103.4) | ||
Lung | 23,027 | 13.9 | 32.6 | 63.9 | 75.5 | 84.8 |
(13.4-14.4) | (31.4-33.8) | (61.8-66.1) | (73.0-78.0) | (81.5-88.1) | ||
Melanoma | 27,888 | 92.6 | 93.8 | 95.9 | 97.3 | 99.0 |
(92.1-93.1) | (93.2-94.3) | (95.3-96.4) | (96.7-97.9) | (98.4-99.6) | ||
Breast (females) | 36,585 | 88.6 | 88.8 | 90.4 | 91.6 | 93.3 |
(88.2-89.0) | (88.3-89.2) | (89.8-90.9) | (91.0-92.1) | (92.6-94.1) | ||
Cervix | 2,368 | 73.2 | 81.4 | 90.7 | 95.1 | 95.3 |
(71.4-75.0) | (79.3-83.5) | (89.0-92.4) | (93.7-96.6) | (93.9-96.8) | ||
Prostate | 39,851 | 90.2 | 90.7 | 91.2 | 90.0 | 89.6 |
(89.6-90.7) | (90.0-91.3) | (90.4-92.0) | (89.1-90.9) | (87.5-91.6) | ||
Kidney | 6,940 | 64.0 | 78.1 | 87.2 | 89.6 | 88.8 |
(62.7-65.4) | (76.4-79.9) | (85.5-89.0) | (87.7-91.4) | (86.1-91.4) | ||
Bladder | 6,154 | 62.5 | 75.1 | 86.0 | 89.8 | 91.5 |
(61.0-64.0) | (73.2-77.1) | (83.9-88.0) | (87.7-92.0) | (89.1-94.0) | ||
Thyroid | 4,508 | 96.0 | 98.7 | 98.8 | 98.9 | 98.3 |
(95.1-96.8) | (97.7-99.6) | (97.9-99.6) | (98.0-99.9) | (97.0-99.6) |